Molecular biology of dysplasia and cancer in inflammatory bowel disease.

[1]  K R Abrams,et al.  Meta‐analysis: colorectal and small bowel cancer risk in patients with Crohn's disease , 2006, Alimentary pharmacology & therapeutics.

[2]  D. Ahlquist,et al.  Aberrant methylation of the eyes absent 4 gene in ulcerative colitis-associated dysplasia. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[3]  A. Stromberg,et al.  Molecular profiling of ulcerative colitis-associated neoplastic progression. , 2006, Experimental and molecular pathology.

[4]  J. Terdiman,et al.  Effect of 5-Aminosalicylate Use on Colorectal Cancer and Dysplasia Risk: A Systematic Review and Metaanalysis of Observational Studies , 2005, The American Journal of Gastroenterology.

[5]  T. Hibi,et al.  Clinical significance of microsatellite instability in the inflamed mucosa for the prediction of colonic neoplasms in patients with ulcerative colitis , 2005, Journal of gastroenterology and hepatology.

[6]  D. Ransohoff,et al.  Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. , 2004, The New England journal of medicine.

[7]  R. Odze,et al.  Long-term follow-up after polypectomy treatment for adenoma-like dysplastic lesions in ulcerative colitis. , 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[8]  S. Itzkowitz,et al.  Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. , 2004, American journal of physiology. Gastrointestinal and liver physiology.

[9]  Alastair Forbes,et al.  Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. , 2004, Gastroenterology.

[10]  C. Fenoglio-Preiser,et al.  Microsatellite Instability Is Uncommon in Intestinal Mucosa of Patients with Crohn's Disease , 2000, Digestive Diseases and Sciences.

[11]  T. Brentnall.  Molecular underpinnings of cancer in ulcerative colitis. , 2003, Current opinion in gastroenterology.

[12]  L. Coussens,et al.  Inflammation and cancer , 2002, Nature.

[13]  S. Toyooka,et al.  Aberrant methylation of the HPP1 gene in ulcerative colitis-associated colorectal carcinoma. , 2002, Cancer research.

[14]  S. Pawlowski,et al.  Elimination of colon cancer in germ-free transforming growth factor beta 1-deficient mice. , 2002, Cancer research.

[15]  M. Gregor,et al.  Epigenetic control of the E‐cadherin gene (CDH1) by CpG methylation in colectomy samples of patients with ulcerative colitis , 2002, Genes, chromosomes & cancer.

[16]  M. Reinshagen,et al.  Screening for p53 and K-ras mutations in whole-gut lavage in chronic inflammatory bowel disease , 2002, European journal of gastroenterology & hepatology.

[17]  J. Potter,et al.  Chromosomal instability in ulcerative colitis is related to telomere shortening , 2002, Nature Genetics.

[18]  D. Chang,et al.  Oxidative stress inactivates the human DNA mismatch repair system. , 2002, American journal of physiology. Cell physiology.

[19]  M. Kohonen-Corish,et al.  Susceptibility of Msh2-deficient mice to inflammation-associated colorectal tumors. , 2002, Cancer research.

[20]  Noam Harpaz,et al.  Artificial neural networks distinguish among subtypes of neoplastic colorectal lesions. , 2002, Gastroenterology.

[21]  F. Waldman,et al.  The APC/β‐catenin pathway in ulcerative colitis–related colorectal carcinomas , 2002, Cancer.

[22]  Suna Wang,et al.  Hypermethylation of the p14(ARF) gene in ulcerative colitis-associated colorectal carcinogenesis. , 2002, Cancer research.

[23]  C. Folwaczny,et al.  K- ras Mutations in Sera of Patients with Colorectal Neoplasias and Long-standing Inflammatory Bowel Disease , 2002, Scandinavian journal of gastroenterology.

[24]  F. Giardiello,et al.  Long-term treatment with sulindac in familial adenomatous polyposis: a prospective cohort study. , 2001, Gastroenterology.

[25]  C. Boland,et al.  Oxidative stress increases frameshift mutations in human colorectal cancer cells. , 2001, Cancer research.

[26]  N. Ahuja,et al.  Accelerated age-related CpG island methylation in ulcerative colitis. , 2001, Cancer research.

[27]  W. Bodmer,et al.  Hypermethylation of the promoter region of the E-cadherin gene (CDH1) in sporadic and ulcerative colitis associated colorectal cancer , 2001, Gut.

[28]  F. Bosman,et al.  Methylation Silencing and Mutations of the p14ARF and p16INK4a Genes in Colon Cancer , 2001, Laboratory Investigation.

[29]  B. Leggett,et al.  HPP1: a transmembrane protein-encoding gene commonly methylated in colorectal polyps and cancers. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[30]  K. Chew,et al.  Altered Distribution of β-Catenin, and Its Binding Proteins E-Cadherin and APC, in Ulcerative Colitis–Related Colorectal Cancers , 2001, Modern Pathology.

[31]  M. Bronner,et al.  The role of cyclooxygenase 2 in ulcerative colitis-associated neoplasia. , 2000, The American journal of pathology.

[32]  C. Hsieh,et al.  Telomerase activity in long-standing ulcerative colitis. , 2000, Anticancer research.

[33]  J. Herman,et al.  Microsatellite instability in inflammatory bowel disease-associated neoplastic lesions is associated with hypermethylation and diminished expression of the DNA mismatch repair gene, hMLH1. , 2000, Cancer research.

[34]  S. Mackell,et al.  Immunohistochemical assessment of Ki67 and p53 expression assists the diagnosis and grading of ulcerative colitis‐related dysplasia , 2000, Histopathology.

[35]  J. Mason,et al.  Effects of dietary folate on DNA strand breaks within mutation-prone exons of the p53 gene in rat colon. , 2000, Gastroenterology.

[36]  K Raja,et al.  Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: a cancer-prone chronic inflammatory disease. , 2000, Cancer research.

[37]  P. Jänne,et al.  Chemoprevention of colorectal cancer. , 2000, The New England journal of medicine.

[38]  C. Fenoglio-Preiser,et al.  Microsatellite instability and K-ras mutations in patients with ulcerative colitis. , 2000, Human pathology.

[39]  D. W. Day,et al.  Defective hMSH2/hMLH1 protein expression is seen infrequently in ulcerative colitis associated colorectal cancers , 2000, Gut.

[40]  J. Herman,et al.  Hypermethylation-associated inactivation of p14(ARF) is independent of p16(INK4a) methylation and p53 mutational status. , 2000, Cancer research.

[41]  F. Waldman,et al.  Chromosomal alterations in ulcerative colitis-related and sporadic colorectal cancers by comparative genomic hybridization. , 2000, Human pathology.

[42]  N. Harpaz,et al.  Colonoscopic polypectomy in chronic colitis: conservative management after endoscopic resection of dysplastic polyps. , 1999, Gastroenterology.

[43]  M. Bronner,et al.  Pancolonic chromosomal instability precedes dysplasia and cancer in ulcerative colitis. , 1999, Cancer research.

[44]  T. Muto,et al.  Genetic Alterations in Ulcerative Colitis‐associated Neoplasia Focusing on APC, K‐ras Gene and Microsatellite Instability , 1999, Japanese journal of cancer research : Gann.

[45]  R. Machinami,et al.  p53 immunohistochemistry of ulcerative colitis‐associated with dysplasia and carcinoma , 1999, Pathology international.

[46]  P S Gartside,et al.  Transforming growth factor beta1 suppresses nonmetastatic colon cancer at an early stage of tumorigenesis. , 1999, Cancer research.

[47]  R. Stenling,et al.  DNA aneuploidy as a marker of premalignancy in surveillance of patients with ulcerative colitis , 1999, The British journal of surgery.

[48]  H. Mitomi,et al.  Enhanced epithelial cell turnover associated with p53 accumulation and high p21WAF1/CIP1 expression in ulcerative colitis. , 1999, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[49]  F. Waldman,et al.  Genomic instability is an early event during the progression pathway of ulcerative-colitis-related neoplasia. , 1999, The American journal of pathology.

[50]  J. Goldblum,et al.  Evaluation of the usefulness of testing for p53 mutations in colorectal cancer surveillance for ulcerative colitis , 1999, American Journal of Gastroenterology.

[51]  C. Fenoglio-Preiser,et al.  A germline hMSH2 alteration is unrelated to colonic microsatellite instability in patients with ulcerative colitis. , 1999, Human pathology.

[52]  C. Bodian,et al.  Sialyl-Tn antigen as a marker of colon cancer risk in ulcerative colitis: relation to dysplasia and DNA aneuploidy. , 1998, Gastroenterology.

[53]  S Srivastava,et al.  A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. , 1998, Cancer research.

[54]  D. Schaid,et al.  Familial predisposition for colorectal cancer in chronic ulcerative colitis: a case-control study. , 1998, Gastroenterology.

[55]  L. Glória,et al.  Microsatellite instability in non-neoplastic mucosa of patients with ulcerative colitis: effect of folate supplementation , 1998, American Journal of Gastroenterology.

[56]  C. Hsieh,et al.  Hypermethylation of the p16INK4a promoter in colectomy specimens of patients with long-standing and extensive ulcerative colitis. , 1998, Cancer research.

[57]  S N Thibodeau,et al.  Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. , 1998, Cancer research.

[58]  E. Giovannucci,et al.  Family history as a risk factor for ulcerative colitis-associated colon cancer in cotton-top tamarin. , 1998, Gastroenterology.

[59]  M. Gregor,et al.  Comparative analysis of histology, DNA content, p53 and Ki‐ ras mutations in colectomy specimens with long‐standing ulcerative colitis , 1998, International journal of cancer.

[60]  W. Bodmer,et al.  A comparison of the genetic pathways involved in the pathogenesis of three types of colorectal cancer , 1998, The Journal of pathology.

[61]  F. Waldman,et al.  Chromosomal alterations in ulcerative colitis-related neoplastic progression. , 1997, Gastroenterology.

[62]  J. Herman,et al.  Association between CpG island methylation and microsatellite instability in colorectal cancer. , 1997, Cancer research.

[63]  M. Gregor,et al.  Distribution of cell populations with DNA aneuploidy and p53 protein expression in ulcerative colitis , 1997, European journal of gastroenterology & hepatology.

[64]  Christopher D. Heinen,et al.  Regenerative lesions in ulcerative colitis are characterized by microsatellite mutation , 1997, Genes, chromosomes & cancer.

[65]  W. Bodmer,et al.  Allele loss, replication errors and loss of expression of E-cadherin in colorectal cancers. , 1997, Gut.

[66]  S. Kern,et al.  DPC4 gene mutation in colitis associated neoplasia. , 1997, Gut.

[67]  B. Leggett,et al.  A transforming growth factor beta 1 receptor type II mutation in ulcerative colitis-associated neoplasms. , 1997, Gastroenterology.

[68]  Suna Wang,et al.  Infrequent DPC4 gene mutation in esophageal cancer, gastric cancer and ulcerative colitis-associated neoplasms. , 1996, Oncogene.

[69]  Sajeev P. Cherian,et al.  Microsatellite instability in nonneoplastic mucosa from patients with chronic ulcerative colitis. , 1996, Cancer research.

[70]  C. Bodian,et al.  Sialosyl-Tn antigen is prevalent and precedes dysplasia in ulcerative colitis: a retrospective case-control study. , 1996, Gastroenterology.

[71]  I. Talbot,et al.  p53 expression in ulcerative colitis: a longitudinal study. , 1995, Gut.

[72]  M. Bronner,et al.  A germline substitution in the human MSH2 gene is associated with high-grade dysplasia and cancer in ulcerative colitis. , 1995, Gastroenterology.

[73]  N. Harpaz,et al.  Adenomatous polyposis coli gene mutations in ulcerative colitis-associated dysplasias and cancers versus sporadic colon neoplasms. , 1995, Cancer research.

[74]  K. Kinzler,et al.  Common occurrence of APC and K-ras gene mutations in the spectrum of colitis-associated neoplasias. , 1995, Gastroenterology.

[75]  T. Tong,et al.  p53 protein expression in ulcerative colitis-associated colorectal dysplasia and carcinoma. , 1994, Human pathology.

[76]  N. York,et al.  Advances in Brief Microsatellite Instability in Ulcerative Colitis-associated Colorectal Dysplasias and Cancers ' , 2006 .

[77]  P. Rabinovitch,et al.  Mutations in the p53 gene: an early marker of neoplastic progression in ulcerative colitis. , 1994, Gastroenterology.

[78]  K. Kinzler,et al.  Molecular genetic profiles of colitis-associated neoplasms. , 1994, Gastroenterology.

[79]  C. Rubio,et al.  DNA aneuploidy and histologic dysplasia in long-standing ulcerative colitis , 1994, Diseases of the colon and rectum.

[80]  J. Benhattar,et al.  K-ras mutations and p53 alterations in neoplastic and nonneoplastic lesions associated with longstanding ulcerative colitis. , 1994, The American journal of pathology.

[81]  C. Cartwright,et al.  Elevated c-Src tyrosine kinase activity in premalignant epithelia of ulcerative colitis. , 1994, The Journal of clinical investigation.

[82]  N. Harpaz,et al.  p53 point mutations in dysplastic and cancerous ulcerative colitis lesions. , 1993, Gastroenterology.

[83]  M. Kimmey,et al.  DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis. , 1992, Gastroenterology.

[84]  P. Rabinovitch,et al.  Neoplastic progression in ulcerative colitis: histology, DNA content, and loss of a p53 allele. , 1992, Gastroenterology.

[85]  C. Compton,et al.  c-Ki-ras mutations in dysplastic fields and cancers in ulcerative colitis. , 1992, Gastroenterology.

[86]  R. Löfberg,et al.  DNA aneuploidy in ulcerative colitis: reproducibility, topographic distribution, and relation to dysplasia. , 1992, Gastroenterology.

[87]  T. McDaniel,et al.  Loss of heterozygosity affecting the p53, Rb, and mcc/apc tumor suppressor gene loci in dysplastic and cancerous ulcerative colitis. , 1992, Cancer research.

[88]  R. Löfberg,et al.  Highly malignant carcinoma in chronic ulcerative colitis without preceding dysplasia or DNA aneuploidy , 1992, Diseases of the colon and rectum.

[89]  T. Rognum,et al.  Flow cytometric DNA ploidy pattern in dysplastic mucosa, and in primary and metastatic carcinomas in patients with longstanding ulcerative colitis. , 1991, British Journal of Cancer.

[90]  G. Taylor,et al.  c-Ki-ras gene mutations in dysplasia and carcinomas complicating ulcerative colitis. , 1991, British Journal of Cancer.

[91]  T. Muto,et al.  Microspectrophotometric DNA analysis in ulcerative colitis with special reference to its application in diagnosis of carcinoma and dysplasia. , 1990, Gut.

[92]  P. Rabinovitch,et al.  c-Ki-ras mutations in chronic ulcerative colitis and sporadic colon carcinoma. , 1990, Gastroenterology.

[93]  S. Mane,et al.  Activation of c-Ki-ras in human gastrointestinal dysplasias determined by direct sequencing of polymerase chain reaction products. , 1990, Cancer research.

[94]  C. Cartwright,et al.  Activation of the pp60c-src protein kinase is an early event in colonic carcinogenesis. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[95]  J. Jass,et al.  Dysplasia and deoxyribonucleic acid aneuploidy in the assessment of precancerous changes in chronic ulcerative colitis. Observer variation and correlations. , 1988, Gastroenterology.

[96]  H. Roels,et al.  The DNA content in cancer and dysplasia in chronic ulcerative colitis , 1987, Histopathology.

[97]  R. Löfberg,et al.  Flow cytometric DNA analysis in longstanding ulcerative colitis: a method of prediction of dysplasia and carcinoma development? , 1987, Gut.

[98]  P. Quirke,et al.  DNA aneuploidy in ulcerative colitis. , 1986, Gut.

[99]  M. Sivak,et al.  Surveillance for colonic carcinoma in ulcerative colitis. , 1985, Gastroenterology.

[100]  P. Slezak,et al.  Early detection of malignancy in ulcerative colitis a flow‐cytometric dna study , 1984, Cancer.

[101]  J. Lennard-jones,et al.  CANCER SURVEILLANCE IN ULCERATIVE COLITIS Experience over 15 years , 1983, The Lancet.